Browsing "Endocrinology & Metabolism" by Journal : Journal of diabetes investigation
Showing results 1 to 12 of 12
Pub Year | | Title | AJOU Author(s) |
2022 | | Cardiovascular disease in patients with type 2 diabetes | 김대중, 전자영 |
2024 | | Effectiveness and safety of sodium–glucose cotransporter 2 inhibitors in Asian populations | 김대중, 하경화 |
2013 | | Effects of patient-tailored atorvastatin therapy on ameliorating the levels of atherogenic lipids and inflammation beyond lowering low-density lipoprotein cholesterol in patients with type2 diabetes. | 김혜진 |
2023 | | Empagliflozin is associated with lower risk of cardiovascular events and all-cause mortality in routine care in East Asia: Results from the EMPRISE study | 김대중, 하경화 |
2018 | | Failure of monotherapy in clinical practice in patients with type 2 diabetes: The Korean National Diabetes Program | 김대중, 김혜진, 이관우, 전자영, 한승진 |
2022 | | Healthcare resource utilization in patients treated with empagliflozin in East Asia | 김대중, 하경화 |
2017 | | Lessons from a cardiovascular outcome trial with liraglutide in type 2 diabetes | 김대중, 김혜진 |
2015 | | New risk factors for obesity and diabetes: Environmental chemicals. | 김대중, 전자영, 하경화 |
2022 | | Prevalence and clinical characteristics of fulminant type 1 diabetes mellitus in Korean adults: A multi-institutional joint research | 김대중, 전자영 |
2022 | | Sodium–glucose cotransporter 2 inhibitors do not increase the risk of fractures in real-world clinical practice in Korea: A national observational cohort study | 김대중, 최용준, 하경화 |
2021 | | Trends in the effects of pre-transplant diabetes on mortality and cardiovascular events after kidney transplantation | 박범희, 오창권, 전자영, 하경화, 한승진 |
2016 | | Urinary adiponectin and progression of diabetic nephropathy in type 1 diabetes | 김대중, 하경화 |
1